This #TalkClinicalTrials blog highlights a powerful patient-led initiative from Rethink Breast Cancer calling for greater inclusion of people living with metastatic breast cancer (MBC) in
Written by WHO Secretariat for Strengthening Clinical Trials For decades, clinical trials have been a cornerstone of health progress, informing what works, what is safe,
This #TalkClinicalTrials blog explores why it’s time to reject gift cards as incentives in research. While gift cards remain a common choice, evidence and participant
This #TalkClinicalTrials blog is by Drs. David Moher and An-Wen Chan who are both Ontario-based researchers. Dr. Moher is a clinical epidemiologist at the University
A new article from Healthing.ca spotlights how CanReview is helping to overcome long-standing provincial barriers to clinical trials by enabling a single research ethics review for multi-site
In this #TalkClinicalTrials blog, Kim Meeking, Co-lead Queering Cancer explores why 2SLGBTQ+ inclusion in clinical trials must go beyond intention—embedding allyship into every step of
